PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.
Also called NCT02463851
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 212 participants
- Sponsor
- L.V.A. Boersma
- Registry
-
NCT02463851
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT02463851. Randomized; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2021-04-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation
- Acronym
- GOLD-FORCE
- Condition
- Atrial Fibrillation
- Intervention (Device)
- PVAC GOLD multielectrode catheter
- Intervention (Device)
- Contact Force single-tip ablation catheter
- Lead sponsor
- L.V.A. Boersma
Record details
- Record id
cardio:ct-nct02463851- Content hash
4d894d946d8f2ca00a10143d27d5f68c4cd5d6992e4f8e46a04b2a8ba92118de